2seventy bio Inc
(NAS:TSVT)
$
3.7275
-0.04 (-1.06%)
Market Cap: 191.61 Mil
Enterprise Value: 264.98 Mil
PE Ratio: 0
PB Ratio: 0.92
GF Score: 38/100 - Q1 2024 2Seventy Bio Inc Earnings Call TranscriptMay 08, 2024$4.48 (-9.68%)Earnings
- Q4 2023 2Seventy Bio Inc Earnings Call TranscriptMar 05, 2024$5.79 (+6.83%)Earnings
- 2Seventy Bio Inc Investor Call TranscriptDec 12, 2023
- Q3 2023 2Seventy Bio Inc Earnings Call TranscriptNov 14, 2023$2.28 (+0.88%)Earnings
- 2Seventy Bio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- 2Seventy Bio Inc Conference Call TranscriptSep 12, 2023
- Q2 2023 2Seventy Bio Inc Earnings Call TranscriptAug 14, 2023$6.03 (+1.34%)Earnings
- 2seventy bio, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 03:20 PM TranscriptJun 14, 2023
- 2Seventy Bio Inc R&D Deep Dive Presentation (Virtual) TranscriptMay 19, 2023
- Q1 2023 2Seventy Bio Inc Earnings Call TranscriptMay 03, 2023$10.05 (-1.28%)Earnings
- Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 2Seventy Bio Inc Earnings Call TranscriptAug 10, 2022$17.22 (+3.11%)Earnings
- 2Seventy Bio Inc Focus on bNHL and Solid Tumor Strategy Conference Call TranscriptSep 22, 2021
- 2Seventy Bio Inc Introduction to 2seventy's Pipeline and Next-Gen Multiple Myeloma Strategy Conference Call TranscriptSep 21, 2021
2Seventy Bio Inc R&D Deep Dive Presentation (Virtual) Transcript
May 19, 2023 / 02:00PM GMT
Release Date Price:
$11.42
(+2.88%)
Jenn Snyder
2seventy bio, Inc. - SVP of Corporate Affairs
Presentation (Virtual)
May 19, 2023 / 02:00PM GMT
=====================
Corporate Participants
=====================
* Jenn Snyder
2seventy bio, Inc. - SVP of Corporate Affairs
* Michael Certo
* Nick Leschly
2seventy bio, Inc. - President, CEO & Director
* Philip D. Gregory
2seventy bio, Inc. - Chief Scientific Officer
* Steven Bernstein
2seventy bio, Inc. - Chief Medical Officer
* Steven Shamah
* William D. Baird
2seventy bio, Inc. - CFO
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)